Skip to content
Peptigraph home
Shop Peptides50% off*

Is Kisspeptin-10 Legal? FDA, Compounding and WADA Status

Kisspeptin-10's FDA status, compounding rules and anti-doping status, with a dated timeline of every change we track.

Medical review pendingGnRH stimulatorUpdated
FDA status
Not approved
research chemical
PCAC vote
Not reviewed
not on the Jul 2026 PCAC agenda
WADA
Prohibited (S2.2.1)
In and out of competition
Not legal adviceStatus reflects public FDA and WADA records on the date shown. Rules differ by country and state.

Current status

Not FDA approved · research chemical

No. Kisspeptin-10 is not FDA approved for any use.

Kisspeptin-10: regulatory status by country
CountryStatusSource
United StatesNo approved product foundNo FDA-approved product found: Drugs@FDA (openFDA) search for active ingredient "Kisspeptin-10" returned no matches on 2 Oct 2026.api.fda.govchecked 2 Oct 2026

Timeline

No FDA, advisory-committee or WADA action specific to Kisspeptin-10 found in our records (checked 2 Oct 2026).
Every peptide on the FDA tracker

Compounding and research-use sellers

  • Category 2 is the FDA's list of bulk substances it flagged as raising significant safety concerns. Compounding pharmacies are not expected to compound from them while they are on it.
  • The Pharmacy Compounding Advisory Committee (PCAC) advises the FDA on which substances belong on the 503A bulks list that pharmacies may compound from. Its votes are advice; the FDA decides.
  • "Research use only" products are sold outside these rules and are not checked by the FDA for identity, purity or dose.

FDA compounding record: Kisspeptin-10 is in FDA's 503A category 2 (significant safety risks), added 29 September 2023. · fda.gov, checked 2 Oct 2026

Sport and drug testing

Prohibited by WADA (S2.2.1)

Kisspeptin and its agonist analogues are named in S2.2.1 (testosterone-stimulating peptides in males).

Outside the US

Rules differ by country. What each regulator's own records show, with the date we checked:

Kisspeptin-10: regulatory status by country
CountryStatusSource
United KingdomNo approved product foundNo approved product found in an emc (UK SmPC compendium) search for "Kisspeptin-10" on 2 Oct 2026.medicines.org.ukchecked 2 Oct 2026
CanadaNo approved product foundNo product found in a Health Canada Drug Product Database search for ingredient "Kisspeptin-10" on 2 Oct 2026.health-products.canada.cachecked 2 Oct 2026
AustraliaNo approved product foundNo approved product found in an ARTG search for "kisspeptin" on 2 Oct 2026.tga.gov.auchecked 2 Oct 2026
European UnionNo centrally authorised EU medicine foundEMA medicines list, searched 2 Oct 2026ema.europa.euchecked 2 Oct 2026

Where FDA places kisspeptin-10 for compounding

FDA's safety-risk table lists kisspeptin-10 for 503A compounding, dated September 29, 2023, with a note on immunogenicity risk for certain routes.[3]

The same entry says the agency lacks sufficient information to know whether the drug would cause harm in humans.[3]

An archived copy of the FDA list still names kisspeptin-10.[8]

Sports rule

The WADA 2026 Prohibited List names kisspeptin and its agonist analogues among testosterone-stimulating peptides in males, section S2.2.1.[1]

Searches of other regulators

The Health Canada database returned zero active-ingredient records for kisspeptin.[5]

The Australian ARTG search for kisspeptin found no matching results.[6]

The cached EMA medicines export search found no matching rows.[7]

The Drugs@FDA lookup returned an error response for the ingredient kisspeptin, so there is no labelled dosage schedule to cite.[2]

Common questions

Is Kisspeptin-10 FDA approved?

No. Kisspeptin-10 is not FDA approved for any use.

Is Kisspeptin-10 legal to buy?

It is not an approved drug. Online sellers label it "for research use only, not for human use"; the FDA sent warning letters to five such sellers on 24 Aug 2026. Whether a pharmacy may compound it depends on its FDA bulk-substance status. Rules differ by country.

Is Kisspeptin-10 banned by WADA?

Yes. Prohibited by WADA (S2.2.1), in and out of competition.

Is kisspeptin FDA approved?

The Drugs@FDA ingredient search returned a not-found code.[2]

Is there a kisspeptin dosage schedule?

There is none on a label; the Drugs@FDA lookup for the ingredient says no matches.[2]

More on Kisspeptin-10

DosageDoses used in published studies, with the source for each.CalculatorVial, water and dose to syringe units.Side effectsWhat labels and studies report, and what is unknown.ResultsStudy outcomes and when they were measured.BenefitsClaimed benefits next to what published studies measured.How it worksTarget, mechanism and how long it acts, from the label or studies.

Sources

  1. 1World Anti-Doping Code International Standard Prohibited List 2026World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
  2. 2United States: No FDA-approved product found: Drugs@FDA (openFDA) search for active ingredient "Kisspeptin-10" returned no matches on 2 Oct 2026.U.S. Food and Drug Administration · 2026api.fda.govAccessed 2 Oct 2026
  3. 3US compounding: Kisspeptin-10 is in FDA's 503A category 2 (significant safety risks), added 29 September 2023.U.S. Food and Drug Administration · 2026fda.govAccessed 2 Oct 2026
  4. 4United Kingdom: No approved product found in an emc (UK SmPC compendium) search for "Kisspeptin-10" on 2 Oct 2026.Electronic Medicines Compendium (UK) · 2026medicines.org.ukAccessed 2 Oct 2026
  5. 5Canada: No product found in a Health Canada Drug Product Database search for ingredient "Kisspeptin-10" on 2 Oct 2026.Health Canada · 2026health-products.canada.caAccessed 2 Oct 2026
  6. 6Australia: No approved product found in an ARTG search for "kisspeptin" on 2 Oct 2026.Therapeutic Goods Administration (Australia) · 2026tga.gov.auAccessed 2 Oct 2026
  7. 7EMA medicines export (centrally authorised medicines) (searched 2 Oct 2026)European Medicines Agency · 2026ema.europa.euAccessed 2 Oct 2026
  8. 8Official web pageOfficial web page · web page

Found an error? Report a correction.